NCT00686179View on ClinicalTrials.gov

Investigate the Effect on the QT/QTc Interval of Repeated and Escalating Doses of AZD3480 During 6 Days

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Healthy
Interventions
DRUG

AZD3480

Capsule, oral, single dose, 6 days

DRUG

Moxifloxacin

Capsule(encapsulated), oral, single dose

DRUG

PLACEBO

Capsule, oral, single dose

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY